Zimmer Biomet Holdings Inc (ZBH) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Total Cash From Operating Activities Chart for Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc (ZBH) operating cash flow for FY2025 was USD 1.7B, a 13.2% change from FY2024. Zimmer Biomet Holdings Inc's operating cash flow grew from USD 199.0M in 1998 to USD 1.7B in 2025 (752.8% over 27 years). Operating cash flow compound annual growth rate: 5-year CAGR of 7.1%, 10-year CAGR of 7.2%, 20-year CAGR of 3.3%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.